Profund Advisors’s Diversified Healthcare Trust DHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-19,937
| Closed | -$20K | – | 1012 |
|
|
2022
Q3 | $20K | Sell |
19,937
-3,596
| -15% | -$5.76K | ﹤0.01% | 918 |
|
|
2022
Q2 | $43K | Sell |
23,533
-9,570
| -29% | -$21.9K | ﹤0.01% | 1006 |
|
|
2022
Q1 | $106K | Buy |
33,103
+6,461
| +24% | +$19.7K | ﹤0.01% | 1317 |
|
|
2021
Q4 | $82K | Buy |
26,642
+1,132
| +4% | +$3.66K | ﹤0.01% | 1351 |
|
|
2021
Q3 | $86K | Sell |
25,510
-6,948
| -21% | -$26.2K | ﹤0.01% | 1327 |
|
|
2021
Q2 | $136K | Buy |
32,458
+1,771
| +6% | +$7.31K | ﹤0.01% | 1392 |
|
|
2021
Q1 | $147K | Buy |
30,687
+7,660
| +33% | +$35.3K | 0.01% | 1295 |
|
|
2020
Q4 | $95K | Buy |
23,027
+6,211
| +37% | +$24.5K | ﹤0.01% | 1166 |
|
|
2020
Q3 | $59K | Sell |
16,816
-4,632
| -22% | -$18.1K | ﹤0.01% | 952 |
|
|
2020
Q2 | $95K | Buy |
21,448
+4,736
| +28% | +$16.7K | 0.01% | 908 |
|
|
2020
Q1 | $61K | Sell |
16,712
-13,096
| -44% | -$85.9K | ﹤0.01% | 731 |
|
|
2019
Q4 | $252K | Sell |
29,808
-5,788
| -16% | -$48.8K | 0.01% | 1033 |
|
|
2019
Q3 | $329K | Sell |
35,596
-1,631
| -4% | -$14.1K | 0.02% | 858 |
|
|
2019
Q2 | $308K | Buy |
37,227
+4,360
| +13% | +$36.3K | 0.01% | 907 |
|
|
2019
Q1 | $387K | Buy |
32,867
+10,948
| +50% | +$140K | 0.02% | 767 |
|
|
2018
Q4 | $257K | Sell |
21,919
-12,093
| -36% | -$179K | 0.02% | 871 |
|
|
2018
Q3 | $597K | Buy |
34,012
+6,701
| +25% | +$123K | 0.02% | 659 |
|
|
2018
Q2 | $494K | Sell |
27,311
-2,222
| -8% | -$36.7K | 0.02% | 795 |
|
|
2018
Q1 | $462K | Sell |
29,533
-2,748
| -9% | -$45.7K | 0.02% | 852 |
|
|
2017
Q4 | $618K | Sell |
32,281
-2,735
| -8% | -$52.4K | 0.02% | 688 |
|
|
2017
Q3 | $685K | Buy |
35,016
+542
| +2% | +$10.6K | 0.03% | 575 |
|
|
2017
Q2 | $705K | Sell |
34,474
-11,685
| -25% | -$249K | 0.03% | 534 |
|
|
2017
Q1 | $935K | Sell |
46,159
-6,919
| -13% | -$136K | 0.04% | 480 |
|
|
2016
Q4 | $1M | Buy |
53,078
+10,642
| +25% | +$206K | 0.05% | 431 |
|
|
2016
Q3 | $964K | Sell |
42,436
-15,596
| -27% | -$345K | 0.05% | 406 |
|
|
2016
Q2 | $1.21M | Buy |
58,032
+8,742
| +18% | +$163K | 0.06% | 306 |
|
|
2016
Q1 | $882K | Buy |
49,290
+18,234
| +59% | +$285K | 0.05% | 403 |
|
|
2015
Q4 | $461K | Buy |
31,056
+753
| +2% | +$11.3K | 0.02% | 688 |
|
|
2015
Q3 | $487K | Sell |
30,303
-9,304
| -23% | -$154K | 0.03% | 577 |
|
|
2015
Q2 | $689K | Sell |
39,607
-11,234
| -22% | -$223K | 0.03% | 584 |
|
|
2015
Q1 | $1.12M | Buy |
50,841
+7,975
| +19% | +$178K | 0.04% | 424 |
|
|
2014
Q4 | $939K | Buy |
42,866
+9,532
| +29% | +$209K | 0.04% | 475 |
|
|
2014
Q3 | $691K | Sell |
33,334
-14,820
| -31% | -$336K | 0.03% | 534 |
|
|
2014
Q2 | $1.16M | Buy |
48,154
+5,731
| +14% | +$134K | 0.05% | 405 |
|
|
2014
Q1 | $945K | Buy |
42,423
+603
| +1% | +$13.2K | 0.04% | 496 |
|
|
2013
Q4 | $921K | Sell |
41,820
-1,125
| -3% | -$26K | 0.04% | 574 |
|
|
2013
Q3 | $993K | Buy |
42,945
+8,485
| +25% | +$205K | 0.05% | 440 |
|
|
2013
Q2 | $886K | Buy |
+34,460
| New | +$935K | 0.06% | 320 |
|
Other funds holding DHC
FFL
H2CM
GAMC
Profund Advisors's DHC Position: Q4 2022 in Review
Profund Advisors sold out of Diversified Healthcare Trust (DHC) in Q4 2022, closing a stake of 19,937 shares — an estimated $20K sold.
Profund Advisors first reported a position in DHC in Q2 2013 and held it in 38 quarters. The position peaked at $1.21M in Q2 2016. 182 funds tracked by Wall St. Rank hold DHC as of Q4 2022.
- Profund Advisors reported no remaining Diversified Healthcare Trust position as of Q4 2022 after selling out during the quarter.
- Profund Advisors sold 19,937 Diversified Healthcare Trust shares in Q4 2022, an estimated $20K.
- Profund Advisors first reported a position in Diversified Healthcare Trust in Q2 2013 and held it in 38 quarters.
- Profund Advisors's Diversified Healthcare Trust position peaked at $1.21M in Q2 2016.
- 182 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q4 2022.
Based on Profund Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.